MACROGENICS INC financial data

Symbol
MGNX on Nasdaq
Location
Rockville, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 430 % +18.3%
Quick Ratio 14.12 % +3.7%
Debt-to-equity 225 % +70.4%
Return On Equity -98.3 % -9.9%
Return On Assets -30.28 % +21.5%
Operating Margin -89 % -17.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63,258,532 shares +0.79%
Common Stock, Shares, Outstanding 63,258,532 shares +0.79%
Entity Public Float 259,400,000 USD
Common Stock, Value, Issued 633,000 USD +0.96%
Weighted Average Number of Shares Outstanding, Basic 63,233,266 shares +0.78%
Weighted Average Number of Shares Outstanding, Diluted 63,283,624 shares +0.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 127,625,000 USD -9.7%
Research and Development Expense 152,088,000 USD -18.1%
General and Administrative Expense 57,736,000 USD +3.5%
Costs and Expenses 241,209,000 USD -2.9%
Operating Income (Loss) -113,584,000 USD -6.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 16,822,000 USD -70.1%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -75,886,000 USD +22.3%
Earnings Per Share, Basic -1 USD/shares +24.7%
Earnings Per Share, Diluted -1 USD/shares +24.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 80,129,000 USD -55.4%
Accounts Receivable, after Allowance for Credit Loss, Current 69,230,000 USD +6.9%
Inventory, Net 8,750,000 USD +1.7%
Assets, Current 232,091,000 USD +4.5%
Property, Plant and Equipment, Net 13,975,000 USD -26.8%
Operating Lease, Right-of-Use Asset 23,305,000 USD +5.9%
Other Assets, Noncurrent 1,392,000 USD +17.5%
Assets 270,763,000 USD +2.4%
Accounts Payable, Current 5,940,000 USD -10.2%
Accrued Liabilities, Current 23,087,000 USD -6.3%
Contract with Customer, Liability, Current 10,302,000 USD -55.8%
Liabilities, Current 44,470,000 USD -25%
Contract with Customer, Liability, Noncurrent 55,840,000 USD +0.61%
Operating Lease, Liability, Noncurrent 31,868,000 USD +8.6%
Other Liabilities, Noncurrent 1,328,000 USD +4.1%
Liabilities 203,762,000 USD +41.1%
Retained Earnings (Accumulated Deficit) -1,230,183,000 USD -6.6%
Stockholders' Equity Attributable to Parent 67,001,000 USD -44.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 67,001,000 USD -44.2%
Liabilities and Equity 270,763,000 USD +2.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -46,890,000 USD -2.7%
Net Cash Provided by (Used in) Financing Activities -282,000 USD -2.1%
Net Cash Provided by (Used in) Investing Activities 9,902,000 USD -60.1%
Common Stock, Shares Authorized 125,000,000 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -37,270,000 USD -80.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 80,129,000 USD -55.4%
Deferred Tax Assets, Valuation Allowance 401,297,000 USD +9.9%
Deferred Tax Assets, Gross 410,197,000 USD +9.9%
Operating Lease, Liability 37,461,000 USD +10.3%
Payments to Acquire Property, Plant, and Equipment 529,000 USD -63.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75,895,000 USD +22.2%
Lessee, Operating Lease, Liability, to be Paid 70,482,000 USD +0.29%
Property, Plant and Equipment, Gross 106,787,000 USD -3.1%
Operating Lease, Liability, Current 5,141,000 USD +8.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5,507,000 USD +8.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 5,185,000 USD +29.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 33,021,000 USD -9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6,258,000 USD +48.7%
Unrecognized Tax Benefits 9,334,000 USD +19.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7,413,000 USD +50.5%
Depreciation, Depletion and Amortization 1,771,000 USD -3.8%
Deferred Tax Assets, Net of Valuation Allowance 8,900,000 USD +5.9%
Share-based Payment Arrangement, Expense 22,889,000 USD +1.6%
Interest Expense 4,211,000 USD +2.7%